Live Quote · NASDAQGELSHealthcare· Drug Manufacturers - Specialty & Generic

Gelteq Limited Ordinary Shares

$0.58 12.17%($-0.08)
TickerSpark Score
29/100
Poor
20
Valuation
40
Profitability
20
Growth
36
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GELS research report →

52-Week Range12% of range
Low
$0.39
Current
$0.58
High
$2.02
Company Overviewwww.gelteq.com

About the company

Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.

CEO
Nathan Jacob Givoni
IPO
2024
Employees
7
HQ
Caulfield, VIC, AU

Price Chart

-66.87% · this period
$1.95$1.17$0.39Jul 02Dec 31Jul 02
Valuation
Market Cap
$5.32M
P/E
0.00
P/S
46.28
P/B
0.00
EV/EBITDA
-3.27
Div Yield
0.00%
Profitability
Gross Margin
100.00%
Op Margin
-3317.65%
Net Margin
-4011.86%
ROE
-42.99%
ROIC
-27.41%
Growth & Income
Revenue
$165.65K · 0.00%
Net Income
$-6,645,453 · -87.40%
EPS
$0.00 · 0.00%
Op Income
$-5,495,527
FCF YoY
-405.80%
Performance & Tape
52W High
$2.02
52W Low
$0.39
50D MA
$0.62
200D MA
$0.89
Beta
-0.54
Avg Volume
3.70M

Get TickerSpark's AI analysis on GELS

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Mar 18, 26WYNNE Paul Michaelother0
Mar 18, 26Szewach Simon Hother0
Jul 1, 26Szewach Simon Hother65,000
Mar 18, 26Karp Bradley Glennother0
Mar 18, 26Givoni Nathan Jother0
Jul 1, 26Givoni Nathan Jother15,000
Coverage · GELS

Our GELS coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on GELS yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate GELS report →
Internal Compare

Similar companies

Peers in the same neighborhood.